Sen­a­tors call on HHS to in­ves­ti­gate McK­in­sey's al­leged ties with FDA, opi­oid man­u­fac­tur­ers

McK­in­sey may be in even deep­er trou­ble than it seemed last year. Last sum­mer, Sen­ate De­moc­rats called on the FDA to look in­to ac­cu­sa­tions that the con­sult­ing firm failed to dis­close po­ten­tial con­flicts of in­ter­est as it worked with both the reg­u­la­to­ry agency and opi­oid man­u­fac­tur­ers at the same time.

Un­sat­is­fied with the an­swers they got, the law­mak­ers are now turn­ing to the HHS’ in­spec­tor gen­er­al for some res­o­lu­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.